Showing results (551-560 of 638) with videos related to

Sort By:
Pageof 64
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|July 1, 2026
Diagnosis of Alzheimer's disease and related dementias and outmigration of older Puerto Rican Medicare Fee-for-service beneficiaries, 2012-2019Jeung Hyun Kim, Yoojin Lee, Yanru Liao, et al.
JAMA Network Open|May 1, 2025
Gender-Affirming Surgery for Transgender and Gender Diverse Medicare BeneficiariesEm Balkan, Gray Babbs, David J Meyers, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Comparative chemical genomics in Babesia species identifies the alkaline phosphatase phoD as a novel determinant of resistanceCaroline D Keroack, Brendan Elsworth, Jacob A Tennessen, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
4-Aryl Pyrrolidines as Novel Orally Efficacious Antimalarial Agents. Part 2: 2-Aryl-N-(4-arylpyrrolidin-3-yl)acetamidesMarvin J Meyers, Jianguang Liu, Zhijun Liu, et al.
Cancer Research|July 1, 1986
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsyF M Torti, M M Bristow, B L Lum, et al.
Substance Abuse|February 22, 2022
Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in PennsylvaniaS Kawasaki, G Hwang, K Buckner, et al.
Journal of Medical Virology|January 19, 2021
Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection studyKristin J Meyers, Brian Dillman, Charles Williams, et al.
Angewandte Chemie (International Ed. in English)|September 25, 2014
Atomic layer deposition overcoating: tuning catalyst selectivity for biomass conversionHongbo Zhang, Xiang-Kui Gu, Christian Canlas, et al.
Frontiers in Oncology|February 5, 2026
Heterogeneous DNA methylation and gene expression patterns underly metabolic plasticity in canine astrocytoma-derived stem-like cellsRyan G Toedebusch, Chang-Il Hwang, Shafee Syed-Quadri, et al.
Cancer|May 13, 2004
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II TrialPrimo N Lara, Karen Giselle Chee, Jeff Longmate, et al.
Pageof 64